Nephron Recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution
Nephron Pharmaceuticals is recalling Ipratropium Bromide and Albuterol Sulfate inhalation solution due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of non-sterile contamination in an inhalation product.
Plain-English summary
Nephron Pharmaceuticals Corp. is recalling Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution. The affected product is packaged in 30x3 mL sterile unit-dose vials, available in 30-count and 60-count cartons. The recall covers Lot D4E20A and Lot D4C21A, both with an expiration date of 3/2016.
The recall was initiated due to a lack of assurance of sterility and the potential exposure to non-sterile lubricant during the filling process. The product was distributed nationwide. The total quantity recalled is 85,248 cartons of the 30-count package and 35,292 cartons of the 60-count package.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or healthcare provider for a replacement or refund. This is a prescription-only medication used for respiratory conditions.
The recalled product
- Product
- IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)
- Brand
- IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
- Manufacturer
- Nephron Pharmaceuticals Corp.
- Category
- Drug — Inhalation Solution
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- a) Lot D4E20A
- exp 3/2016 and b) Lot D4C21A
- exp 3/2016
UPCs (1)
- 0304870201018
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
- HighPrescription respiratory drug recalled for short fill in unit-dose vials
FDA (Drugs) · 2024-05-01
- HighRespiratory inhalation medication recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03
- ModerateIpratropium Bromide and Albuterol Sulfate inhalation solution recalled for temperature abuse
FDA (Drugs) · 2022-06-15
Same manufacturer · Nephron Pharmaceuticals Corp.
See all →- HighNephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
FDA (Devices) · 2016-07-06
- HighNephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
FDA (Devices) · 2016-07-06
- ModerateNephron Recalls Asthmanefrin Racepinephrine Inhalation Solution Due to Discoloration
FDA (Drugs) · 2015-12-09
- ModerateNephron Recalls Asthmanefrin Inhalation Solution Due to Discoloration
FDA (Drugs) · 2015-12-09
- SevereNephron Recalls Albuterol Sulfate Inhalation Solution Due to Sterility Concerns
FDA (Drugs) · 2013-10-30
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereNephron Recalls Albuterol Sulfate Inhalation Solution Due to Sterility Concerns
FDA (Drugs) · 2013-10-30
- ModerateNephron albuterol inhalation solution vials recalled over an illegible label
FDA (Drugs) · 2026-04-22
- ModerateIpratropium Bromide and Albuterol Sulfate inhalation solution recalled for temperature abuse
FDA (Drugs) · 2022-06-15
- HighPrescription respiratory drug recalled for short fill in unit-dose vials
FDA (Drugs) · 2024-05-01
- HighNephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
FDA (Devices) · 2016-07-06
- HighRespiratory inhalation medication recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03